skip to Main Content

The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes

Newsfeed image, light gray text on dark gray background
Pancreatic cancer is a highly fatal malignancy with overall 5-year survival of under 10%, within the context of increasing incidence rates worldwide.

Even among the minority of patients who are diagnosed with early stage disease and undergo resection, most survive less than 5 years (short-term survivors (STS), however a unique subset of patients survive >5 years post-surgery coined long-term survivors.

Recent human and mice studies suggests that the gut microbiome may play a role in pancreatic cancer initiation and progression through immune system modulation. Read more . . . 

Back To Top